Web Exclusives
Web Exclusives — September 20, 2021
The first head-to-head trial of these drugs shows comparable efficacy with a better cardiovascular safety profile for acalabrutinib. Read More ›
Web Exclusives — September 20, 2021
A recent study provides some of the first data on COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Read More ›
Web Exclusives — September 20, 2021
Preliminary results from the ongoing ALPINE study suggest that zanubrutinib may have superior efficacy and an improved safety profile compared with ibrutinib in previously treated patients with chronic lymphocytic leukemia. Read More ›
Web Exclusives — September 20, 2021
Results from the 4-year follow-up of the ELEVATE-TN study support acalabrutinib with or without immunotherapy in previously untreated patients with chronic lymphocytic leukemia. Read More ›
Web Exclusives — September 20, 2021
Being diagnosed with cancer and undergoing subsequent treatment can be challenging for patients and their partners, but intimacy does not have to end. Read More ›
Web Exclusives — September 1, 2021
Patients with cancer can take a proactive role in their overall well-being by finding out what types of activities work best for them to combat feelings of isolation. Read More ›
Web Exclusives — August 2, 2021
As we recognize National Immunization Awareness Month, let’s focus on building awareness of the latest vaccination guidance and requirements to support parents of children and teens with pediatric cancer. Read More ›
Web Exclusives — July 6, 2021
Cancer treatment is complicated; an oncology patient advocate can help uncomplicate the journey by advocating and being a voice for their patients with cancer. Read More ›